Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.

Also called NCT06578234

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
  • Region Skane Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06578234
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06578234. Randomized; single masking; primary purpose diagnostic. Start 2024-10-23 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
Acronym
HYPER
Condition
Chronic Coronary Syndrome
Condition
Ischemic Heart Disease
Intervention (Drug)
Adenosine
Lead sponsor
Region Skane (class: other)

Record details

Record id
cardio:ct-nct06578234
Content hash
80ecf9cac08543b24ade4cf000d80d1a854fc9b6bacd5022b9666c65e21a7593